Drug Information

Drug General Information
Drug ID
D01ZLU
Former ID
DIB010879
Drug Name
TAS-120
Indication Multiple myeloma [ICD9: 203; ICD10:C90] Phase 1/2 [524629]
Company
Taiho oncology
Target and Pathway
Target(s) Fibroblast growth factor receptor Target Info Antagonist [549968]
References
Ref 524629ClinicalTrials.gov (NCT02052778) A Dose Finding Study Followed by a Safety and Efficacy Study in Patients With Advanced Solid Tumors or Multiple Myeloma With FGF/FGFR-Related Abnormalities. U.S. National Institutes of Health.
Ref 549968TAS-120, a highly potent and selective irreversible FGFR inhibitor, is effective in tumors harboring various FGFR gene abnormalities. Molecular Cancer Therapeutics. 01/2014; 12(11_Supplement):A270-A270.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.